Overview
- Defense Secretary Pete Hegseth announced on July 15 that the military will add annual testosterone tests to periodic health exams for service members aged 30 and older while those under 30 may opt in.
- Medical societies and clinicians say the plan departs from established guidance because diagnosis normally requires symptoms plus at least two fasting morning tests before any treatment is begun.
- Experts warn population screening of largely asymptomatic, younger troops risks misdiagnosis and harmful treatments that can cause infertility, increased blood clotting, abnormal heart rhythms and other side effects.
- The Pentagon has not released key details including confirmatory-testing procedures, criteria for prescribing testosterone, whether women will be included, cost estimates or outside clinical advisers.
- Coverage has mixed focus with clinical outlets stressing safety and evidence gaps while opinion pieces emphasize political and cultural frames, and implementation planning now centers on a required policy update by Aug. 15.